| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 3 securities · passive | ||||||
|
Ethos Technologies Inc.
13G/A
LIFE · 29765A101
|
1.8% |
11/6/2026
Event 9/30/2026
|
||||
| GV 2019, L.P. | 0% | |||||
| GV 2019 GP, L.P. | 0% | |||||
| GV 2019 GP, L.L.C. | 0% | |||||
| GV 2021, L.P. | 1.8% | |||||
| GV 2021 GP, L.P. | 1.8% | |||||
| GV 2021 GP, L.L.C. | 1.8% | |||||
| Alphabet Holdings LLC | 1.8% | |||||
| XXVI Holdings Inc. | 1.8% | |||||
| Alphabet Inc. | 1.8% | |||||
|
Maze Therapeutics, Inc.
13G/A
MAZE · 578784100
|
2.9% |
2/6/2026
Event 12/31/2025
|
||||
| GV 2019, L.P. | 1.6% | |||||
| GV 2019 GP, L.P. | 1.6% | |||||
| GV 2019 GP, L.L.C. | 1.6% | |||||
| GV 2023, L.P. | 1.3% | |||||
| GV 2023 GP, L.P. | 1.3% | |||||
| GV 2023 GP, L.L.C. | 1.3% | |||||
| Alphabet Holdings LLC | 2.9% | |||||
| XXVI Holdings Inc. | 2.9% | |||||
| Alphabet Inc. | 2.9% | |||||
|
Prime Medicine, Inc.
13G/A
PRME · 74168J101
|
12.3% |
11/12/2025
Event 9/30/2025
|
||||
| GV 2019, L.P. | 7.5% | |||||
| GV 2019 GP, L.P. | 7.5% | |||||
| GV 2019 GP, L.L.C. | 7.5% | |||||
| GV 2021, L.P. | 2.4% | |||||
| GV 2021 GP, L.P. | 2.4% | |||||
| GV 2021 GP, L.L.C. | 2.4% | |||||
| GV 2023, L.P. | 2.4% | |||||
| GV 2023 GP, L.P. | 2.4% | |||||
| GV 2023 GP, L.L.C. | 2.4% | |||||
| Alphabet Holdings LLC | 12.3% | |||||
| XXVI Holdings Inc. | 12.3% | |||||
| Alphabet Inc. | 12.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.